Quality Unpacked

Resource · CAPA & quality systems

Risk Assessment: Turning Uncertainty into Better Quality Decisions

A credible risk assessment explains the decision, the evidence, and what remains uncertain. Use a cleaned-equipment hold-time example to move beyond a green score.

A green rating is the start of a question

The assessment is complete, the numbers add up, and the final cell is green. What evidence makes the risk acceptable?

A useful assessment explains what could go wrong, how it could affect quality, what controls matter, and what the team still does not know. Agreement is useful, but agreement alone does not establish the soundness of a conclusion.

Start with the decision the assessment must support. This guide accompanies the Quality Unpacked video and develops its hypothetical cleaned-equipment hold-time example. It is a reasoning exercise, not a study protocol or a recommended hold duration.

Make the question specific enough to investigate

A hypothetical manufacturer wants to extend the time cleaned equipment can stand before reuse. A longer hold would ease scheduling pressure. That benefit explains the proposal; it does not establish that the equipment will remain suitable.

The useful question is whether the equipment can remain clean and suitable for use throughout the proposed longer hold under defined conditions. Specify the equipment configurations, products, storage conditions, protection and operating practices included. State what is outside the assessment.

Evidence for one configuration or storage condition does not automatically cover another. Connect the assessment to the change-control proposal so its boundaries and conclusions follow the change into implementation.

Connect the event to its possible effect

During the extended hold, contamination could be introduced, a protective cover could be disturbed, or storage conditions could differ from those previously evaluated. Explain the pathway from those conditions to a possible effect on product quality and, ultimately, the patient.

A disturbed cover, equipment contamination and patient harm are related concepts, but they are not interchangeable. The product and subsequent processing influence the pathway. Keeping those distinctions visible helps the team choose controls that address the relevant mechanism.

Describe credible scenarios rather than treating every imaginable event as equally plausible. Include people who understand equipment use, cleaning, validation, microbiology where relevant, and quality oversight. The necessary expertise follows the question.

Do not let an assumption become evidence

Separate what is supported, what is assumed and what remains unknown. Existing work may support the current hold under specified conditions. It does not, by itself, support a longer duration or a different storage environment.

A history without recorded contamination is informative only in context. What could the monitoring have detected? Were the relevant equipment, duration and operating conditions represented? Was the information complete enough to support the proposed conclusion?

Make consequential gaps actionable. “Storage conditions are equivalent” is an assumption until supported. Identify what comparison, observation or planned study would address it. A future study is a plan to obtain evidence; it is not evidence already available.

Preserve the distinction between an unknown and an unfavorable result. Both can influence a decision, but they call for different explanations and follow-up.

The total cannot replace the reasoning

A matrix or scoring method can organize a discussion. Define the scales and explain the evidence behind the rating. When reviewers disagree about likelihood, check their definitions and information before averaging opinions.

Consider severity and likelihood. If the selected method also considers detectability, state what can be detected, by which control, and at what point. A visual inspection might detect a damaged cover without establishing the absence of every relevant contaminant.

Different combinations can produce the same total while representing different concerns. Keep the component judgments visible. A low score should not conceal a severe consequence, ineffective protection or major knowledge gap.

No particular matrix, numerical cutoff or scoring formula is prescribed by this article. Use the method appropriate to the decision and your approved quality system.

Match the work to the decision

Some questions can be answered with a brief, well-supported assessment. Others require broader expertise, deeper analysis and additional evidence. The aim is enough rigor for another qualified reader to understand and evaluate the conclusion.

For the proposed extension, a workshop assigning a lower likelihood cannot establish equipment suitability beyond the conditions supported by existing work. The team may need planned supporting studies and review through the applicable change and validation processes.

Uncertainty, complexity and the importance of the decision help inform the level of formality. Scheduling pressure does not reduce uncertainty. Document why the chosen approach is sufficient instead of using urgency as the rationale.

Distinguish planned protection from proven protection

Assessment informs the response; risk control puts it into practice. For this hypothetical example, potential measures might include defined storage conditions, suitable protection, clear equipment status and evidence supporting the hold duration.

For each measure, explain what it prevents or detects, what could compromise it, and how it will be maintained. Training can help people execute the process. It cannot establish that an unsupported hold time is suitable. See Moving Beyond Retraining for related cause-to-action reasoning.

Evaluate the risk remaining after the controls, including any new risk they introduce. Keep proposed measures separate from measures already implemented and shown to perform. Do not describe an intended future state as the current state.

A decision to obtain more evidence is still a decision

The outcome might support the change within defined conditions, require additional information, narrow the proposal, or stop it. In our example, the current limit might remain in place until suitable supporting work is completed and reviewed.

Record the decision, its rationale, outstanding uncertainties, the person or function authorized to accept the risk, and any conditions attached. Make those conditions visible to the people implementing the decision.

Use the appropriate quality-system processes for unexpected findings. Risk assessment does not substitute for an investigation, required approval, or evidence that a control performs as intended.

Keep the conclusion connected to actual use

Assign responsibility and define review triggers. New study results, adverse trends, deviations, equipment changes, altered storage or a failing protective measure may challenge the basis of the decision.

For the longer hold, confirm that routine practice continues to match the conditions that supported acceptance. If a critical assumption changes, revisit the assessment rather than copying the previous rating into a new document.

Distinguish completed implementation from evidence of the intended result. The effectiveness-check guide offers related principles for selecting relevant opportunities, criteria and evidence, without prescribing a universal review interval.

Before approval, ask whether the question is clear, whether the evidence supports the conclusion, and what new information would change the decision.

What the guidance supports

ICH Q9(R1), Quality Risk Management, section 3, links assessment to scientific knowledge and patient protection. Sections 4.3–4.6 address assessment, control, communication and review; sections 5.1–5.3 discuss formality, decisions and subjectivity. Its introduction makes clear that risk management does not override applicable requirements or justify otherwise unacceptable practices. See also FDA’s Q9(R1) guidance page.

EU GMP Annex 15, section 10.8, addresses considering the time between cleaning and use when defining clean hold times; section 11 addresses controlled changes. These are pharmaceutical GMP contexts, not universal requirements for every life-sciences activity.

The questions and example above are practical educational applications, not verbatim guidance, a mandatory template, or product-specific advice. Apply the requirements relevant to your product, operation and markets. No hold duration, sample size, risk-acceptance threshold or universal scoring method is specified here.

Keep the reasoning connected.